Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer

NCT: NCT07259447 · ACTIVE_NOT_RECRUITING

NCT IDNCT07259447
StatusACTIVE_NOT_RECRUITING
Start Date2024-06-21
Completion2026-12-31
SponsorUniversitaire Ziekenhuizen KU Leuven (OTHER)
First posted
Last updated

Brief Summary

Locally advanced non-small cell lung cancer (LA-NSCLC) patients could benefit in overall and progression-free survival from regular dosimetric treatment plan adaptations during radiotherapy. This is known as adaptive radiotherapy (ART). However, implementing an adaptive radiotherapy workflow presents a highly cumbersome process. First, repeated planning-CT imaging during treatment is required, which results in additional radiation dose for patients. Second, an ART workflow includes the repetition of various manual and semi-automated tasks such as target and organ-at-risk contouring on the images and dosimetric treatment planning. These obstacles hinder widespread ART implementation. To avoid repeated planning-CT imaging, position-verification imaging can be utilized. Modern cone-beam CT (CBCT) imaging, integrated into the treatment unit, assists radiation therapists (RTTs) in administering the dose. Recent improvements in CBCT imaging sources and detectors have enhanced image quality. Moreover, it may be possible to calculate radiation dose directly on these CBCTs. Utilizing CBCT imaging for plan adaptation could also eliminate the need for an additional CT procedure, thereby increasing patient comfort. To address the labor-intensive contouring and treatment planning steps, CE-marked and validated commercial AI applications are already being used to support organ contouring and accelerate the treatment-planning process. These tools are currently applied to pre-treatment planning CTs. The time efficiency of these contemporary tools in a prospective ART workflow has yet to be studied, as has the feasibility of applying these applications within a CBCT-based ART workflow.

Frequently Asked Questions

What is Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer?

Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer is a clinical trial registered under NCT07259447. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07259447?

The current status of NCT07259447 (Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer) is: ACTIVE_NOT_RECRUITING.

When did Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer start?

Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer started on 2024-06-21.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.